Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study

Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD

(2018) Anand Srivastava et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation

(2018) Richard J. Johnson et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

(2018) William B. White et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease

(2017) Mai Sugahara et al.   KIDNEY INTERNATIONAL

Disruption of xanthine oxidoreductase gene attenuates renal ischemia reperfusion injury in mice

(2017) Yoshie Haga et al.   LIFE SCIENCES

Oxidative Stress in Hemodialysis Patients: A Review of the Literature

(2017) Vassilios Liakopoulos et al.   Oxidative Medicine and Cellular Longevity

Xanthine oxidase gene variants and their association with blood pressure and incident hypertension

(2016) Lieke E.J.M. Scheepers et al.   JOURNAL OF HYPERTENSION

Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction

(2016) Lucas C. Pinheiro et al.   Redox Biology

Factors influencing the crystallization of monosodium urate: a systematic literature review

(2015) Ashika Chhana et al.   BMC MUSCULOSKELETAL DISORDERS

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis

(2015) Tahir Kanji et al.   BMC Nephrology

Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress

(2014) Maria Giulia Battelli et al.   ATHEROSCLEROSIS

Treatment of calcium nephrolithiasis in the patient with hyperuricosuria

(2014) Omotayo Arowojolu et al.   JOURNAL OF NEPHROLOGY

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis

(2013) Bhadran Bose et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Uric Acid Stones and Hyperuricosuria

(2012) Tapan H. Mehta et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Uric Acid Induces Renal Inflammation via Activating Tubular NF-κB Signaling Pathway

(2012) Yang Zhou et al.   PLoS One

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Potential Pharmacologic Treatments for Cystinuria and for Calcium Stones Associated with Hyperuricosuria

(2011) D. S. Goldfarb   Clinical Journal of the American Society of Nephrology

Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele

(2011) Adrienne Tin et al.   HUMAN MOLECULAR GENETICS

Xanthine Oxidoreductase Depletion Induces Renal Interstitial Fibrosis Through Aberrant Lipid and Purine Accumulation in Renal Tubules

(2009) Toshio Ohtsubo et al.   HYPERTENSION

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system

(2009) Dalila B Corry et al.   JOURNAL OF HYPERTENSION

24-h uric acid excretion and the risk of kidney stones

(2007) G.C. Curhan et al.   KIDNEY INTERNATIONAL